Institutional investors purchased a net $9.2 million shares of FOLD during the quarter ended September 2014 and now own 47.80% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERCEPTIVE ADVISORS LLC Bought 2.1 Million shares of Amicus Therapeutics Inc
CANDRIAM BELGIUM SA Bought 400.0 Thousand shares of Amicus Therapeutics Inc